Deakin University
Browse
lo-optimalstimulation-2003.pdf (492.7 kB)

Optimal stimulation duration of tens in the management of osteoarthritic knee pain

Download (492.7 kB)
Version 2 2024-06-13, 07:51
Version 1 2014-10-27, 16:50
journal contribution
posted on 2024-06-13, 07:51 authored by G Cheing, A Tsui, S Lo, C Hui-Chan
Objective: This study examined the optimal stimulation duration of transcutaneous electrical nerve stimulation (TENS) for relieving osteoarthritic knee pain and the duration (as measured by half-life) of post-stimulation analgesia. Subjects: Thirty-eight patients received either: (i) 20 minutes (TENS20); (ii) 40 minutes (TENS40); (iii) 60 minutes (TENS60) of TENS; or (iv) 60 minutes of placebo TENS (TENSPL) 5 days a week for 2 weeks. Methods: A visual analogue scale recorded the magnitude and pain relief period for up to 10 hours after stimulation. Results: By Day10, a significantly greater cumulative reduction in the visual analogue scale scores was found in the TENS40 (83.40%) and TENS60 (68.37%) groups than in the TENS20 (54.59%) and TENSPL (6.14%) groups (p 3 0.000), such a group difference was maintained in the 2-week followup session (p 3 0.000). In terms of the duration of post-stimulation analgesia period, the duration for the TENS40 (256 minutes) and TENS60 (258 minutes) groups was more prolonged than in the other 2 groups (TENS20 = 168 minutes, TENSPL = 35 minutes) by Day10 (p 3 0.000). However, the TENS40 group produced the longest pain relief period by the follow-up session. Conclusion: 40 minutes is the optimal treatment duration of TENS, in terms of both the magnitude (VAS scores) of pain reduction and the duration of post-stimulation analgesia for knee osetoarthritis.

History

Journal

Journal of rehabilitation medicine

Volume

35

Pagination

62-68

Location

Stockholm, Sweden

Open access

  • Yes

ISSN

1650-1977

Language

eng

Publication classification

C1.1 Refereed article in a scholarly journal

Copyright notice

2003, Taylor & Francis

Issue

2

Publisher

Taylor & Francis A S